Kadmon Announces Expanded Results of Interim Analysis of Pivotal Trial of KD025 in cGVHD
Patient Analyses and Safety Data Continue to Underscore Positive Impact of KD025 in cGVHD Pre-NDA Meeting with FDA Planned for...
Day: February 23, 2020
Patient Analyses and Safety Data Continue to Underscore Positive Impact of KD025 in cGVHD Pre-NDA Meeting with FDA Planned for...